Preoperative XXXX as a Predictor of @entity551 During Anesthetic Induction in Lung Transplant Recipients.

@entity1 @entity551 @entity2944
OBJECTIVE: To determine the incidence and predisposing factors of @entity551 during anesthetic induction in lung transplant recipients. DESIGN: Retrospective study. SETTING: University hospital. @entity1 : @entity1 who underwent lung transplantation between 2008 and 2013 (n = 68). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The authors analyzed the mean arterial pressure (MAP) from administration of anesthetic drugs to 10 minutes after endotracheal intubation (ie, the anesthetic induction) among @entity1 who underwent lung transplantation. @entity1 were considered to have clinically significant @entity551 (CSH) when the following criteria were fulfilled: An MAP decrease of>40% from baseline and MAP of<60 mmHg. Overall, 41.2% of @entity1 experienced CSH during the induction of anesthesia. The preoperative partial pressure of carbon dioxide (PaCO2) was significantly higher in @entity1 who experienced CSH during anesthetic induction than in those who did not (p = 0.005). Preoperative PaCO2 predicted the development of CSH during anesthetic induction (area under the curve = 0.702; p = 0.002), with an optimal cut-off point of 55 mmHg determined by maximizing the Youden index. The incidences of CSH during anesthetic induction for @entity1 with (PaCO2>= 55) and without (PaCO2<55) preoperative @entity2944 were 75.0% (95% confidence interval [CI] [53.8-89.2]) and 30.8% (95% CI 26.4-37.3), respectively. After adjustment for known predicting factors, the odds ratio for the relationship between preoperative @entity2944 and CSH during anesthetic induction was 12.54 (95% CI 3.10-66.66). CONCLUSIONS: @entity551 during anesthetic induction is common in lung transplant recipients, and is independently predicted by preoperative @entity2944 .
